Special Focus Session

SF 7a - Staging of breast cancer

Lectures

1
Chairperson's introduction

Chairperson's introduction

05:00Eva M. Fallenberg, München / DE

2
Local staging: how and when?

Local staging: how and when?

13:00Iva Biondić Špoljar, Zagreb / HR

3
Imaging for metastasis: modality and patient selection

Imaging for metastasis: modality and patient selection

13:00Nuala Healy, Dublin / IE

4
PET: novel tracers and role of PET/MRI

PET: novel tracers and role of PET/MRI

13:00Thiemo Van Nijnatten, Maastricht / NL

5
Whole-body MRI in breast imaging: is it useful?

Whole-body MRI in breast imaging: is it useful?

13:00Anwar R. Padhani, Northwood / UK

6
Utilising large language models to improve comprehension of breast imaging reports

Utilising large language models to improve comprehension of breast imaging reports

10:00Hemal Grover, New York / US

7
Dream and reality: a patient perspective

Dream and reality: a patient perspective

13:00Alexandra Von Korff, Köln / DE

8
Panel discussion: Staging and monitoring of patients: how can we add value?

Panel discussion: Staging and monitoring of patients: how can we add value?

10:00Panel discussion: Staging and monitoring of patients: how can we add value?

5 min
Chairperson's introduction
Eva M. Fallenberg, München / Germany
13 min
Local staging: how and when?
Iva Biondić Špoljar, Zagreb / Croatia
  1. To explain the importance of breast cancer stagingin determining prognosis and guiding treatment decisions.
  2. To differentiate between the various types of staging, including clinical, pathological, and imaging-based staging.
  3. To understand the current guideline-based recommendationsfor imaging and staging work-up in newly diagnosed breast cancer.
13 min
Imaging for metastasis: modality and patient selection
Nuala Healy, Dublin / Ireland
  1. To discuss indications for performing staging for breast cancer metastasis to allow early detection to ensure optimal patient outcomes.
  2. To describe and evaluate current standard imaging techniques utilised in the staging of breast cancer metastasis, discussing strengths and limitations of these established modalities in clinical practice.
  3. To explore novel and emerging imaging techniques and modalities for detecting metastatic breast cancer.
13 min
PET: novel tracers and role of PET/MRI
Thiemo Van Nijnatten, Maastricht / Netherlands
  1. To understand the principle of a one-stop-shop approach using PET-MRI (including a diagnostic breast MRI) in breast cancer patients.
  2. To describe the current shortcomings of 18F-FDG PET in breast cancer patients.
  3. To name the novel PET tracers considered for clinical implementation in breast cancer patients.
13 min
Whole-body MRI in breast imaging: is it useful?
Anwar R. Padhani, Northwood / United Kingdom
  1. To highlight the limitations of traditional imaging in detecting bone deposits and understanding their therapeutic implications.
  2. To know about protocols and common indications for WB-MRI use, focusing on staging assessments.
  3. To address ongoing challenges and unanswered questions about the perceived effectiveness of WB-MRI in staging.
10 min
Utilising large language models to improve comprehension of breast imaging reports
Hemal Grover, New York / United States
  1. To evaluate the performance of large language models (like ChatGPT and Gemini in improving the readability of actionable breast imaging reports (ie BIRADS 3, 4 and 5).
  2. To evaluate the accuracy of LLM-generated layperson reports.
  3. To compare the performance of ChatGPT and Gemini.
13 min
Dream and reality: a patient perspective
Alexandra Von Korff, Köln / Germany
  1. To indicate the expectations and understanding of using staging examinations from a patient's perspective.
  2. To realise the fears and releases patients experience during their treatment path.
10 min
Panel discussion: Staging and monitoring of patients: how can we add value?